Ayuzawa et al. reported that treatment with eplerenone inhibited mineralocorticoid receptor signaling and Nox4 gene upregulation to improve cardiac hypertrophy and dysfunction caused by pressure overload [25]. Here, NOX4 is linked to cardiac hypertrophy.